These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 25261987)
1. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367 [TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival. Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561 [TBL] [Abstract][Full Text] [Related]
4. A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer. Saito T; Kurashige J; Nambara S; Komatsu H; Hirata H; Ueda M; Sakimura S; Uchi R; Takano Y; Shinden Y; Iguchi T; Eguchi H; Ehata S; Murakami K; Sugimachi K; Mimori K Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S915-22. PubMed ID: 25986864 [TBL] [Abstract][Full Text] [Related]
5. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
6. Lymph node metastasis is mediated by suppressor of cytokine signaling-3 in gastric cancer. Deng J; Jiao X; Liu H; Wu L; Zhang R; Wang B; Pan Y; Hao X; Liang H Tumour Biol; 2013 Dec; 34(6):3627-36. PubMed ID: 23824571 [TBL] [Abstract][Full Text] [Related]
7. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. Zhang Q; Ye Z; Yang Q; He X; Wang H; Zhao Z World J Surg Oncol; 2012 Jun; 10():103. PubMed ID: 22681645 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma. Li C; Ji L; Ding ZY; Zhang QD; Huang GR Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma. Hu X; Xin Y; Xiao Y; Zhao J Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316 [TBL] [Abstract][Full Text] [Related]
10. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. Hur H; Kim YB; Ham IH; Lee D J Surg Oncol; 2015 Nov; 112(6):585-91. PubMed ID: 26381042 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas. Jang BG; Lee BL; Kim WH Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner. Ertao Z; Jianhui C; Kang W; Zhijun Y; Hui W; Chuangqi C; Changjiang Q; Sile C; Yulong H; Shirong C Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085 [TBL] [Abstract][Full Text] [Related]
13. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma. Shi R; Wang L; Wang T; Xu J; Wang F; Xu M Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954 [TBL] [Abstract][Full Text] [Related]
14. High SLC17A9 expression correlates with poor survival in gastric carcinoma. Li J; Su T; Yang L; Deng L; Zhang C; He Y Future Oncol; 2019 Dec; 15(36):4155-4166. PubMed ID: 31799885 [No Abstract] [Full Text] [Related]
15. TPX2 expression is associated with poor survival in gastric cancer. Tomii C; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T World J Surg Oncol; 2017 Jan; 15(1):14. PubMed ID: 28069036 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer. Guo J; Zu G; Zhou T; Xing J; Wang Z Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133 [TBL] [Abstract][Full Text] [Related]
17. Lin28 promotes Her2 expression and Lin28/Her2 predicts poorer survival in gastric cancer. Wang Q; Zhou J; Guo J; Teng R; Shen J; Huang Y; Xie S; Wei Q; Zhao W; Chen W; Yuan X; Chen Y; Wang L Tumour Biol; 2014 Nov; 35(11):11513-21. PubMed ID: 25128063 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients? Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944 [TBL] [Abstract][Full Text] [Related]
19. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients. Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]